|
rs1057910
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Carriers of the <i>CYP2C9</i> polymorphisms rs1057910 and rs4086116 had an increased risk of warfarin sensitivity compared to subjects with no or only one polymorphism.
|
31061616 |
2019 |
|
rs4086116
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Carriers of the <i>CYP2C9</i> polymorphisms rs1057910 and rs4086116 had an increased risk of warfarin sensitivity compared to subjects with no or only one polymorphism.
|
31061616 |
2019 |
|
rs17708472
|
|
|
0.010 |
GeneticVariation |
BEFREE |
This study confirmed a genetic association of the <i>CYP2C9</i>*3 and <i>VKORC1</i> rs10871454, rs8050894, rs9934438, and rs17708472 SNPs with warfarin sensitivity.
|
30486437 |
2018 |
|
rs17847036
|
|
|
0.010 |
GeneticVariation |
BEFREE |
From the 40 SNPs analyzed, CYP2C9 rs17847036 and VKORC1 rs9923231 showed significant association with warfarin sensitivity.
|
21639946 |
2011 |
|
rs1799809
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In our study population, no significant correlation could be detected between CYP2C9*3, CYP2C9C-65 (rs9332127), CYP4F2 rs2108622, GGCX rs12714145, EPHX1 rs4653436 and PROC rs1799809 with warfarin sensitivity.
|
21639946 |
2011 |
|
rs4653436
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In our study population, no significant correlation could be detected between CYP2C9*3, CYP2C9C-65 (rs9332127), CYP4F2 rs2108622, GGCX rs12714145, EPHX1 rs4653436 and PROC rs1799809 with warfarin sensitivity.
|
21639946 |
2011 |
|
rs9332127
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In our study population, no significant correlation could be detected between CYP2C9*3, CYP2C9C-65 (rs9332127), CYP4F2 rs2108622, GGCX rs12714145, EPHX1 rs4653436 and PROC rs1799809 with warfarin sensitivity.
|
21639946 |
2011 |
|
rs9923231
|
|
|
0.010 |
GeneticVariation |
BEFREE |
From the 40 SNPs analyzed, CYP2C9 rs17847036 and VKORC1 rs9923231 showed significant association with warfarin sensitivity.
|
21639946 |
2011 |